Cargando…

The comparison of the three assays for determination of fecal calprotectin in inflammatory bowel disease

INTRODUCTION: Fecal calprotectin is a biomarker for monitoring inflammatory bowel disease (IBD) activity. Our aim, therefore, was to evaluate two new assays, the point of care test Quantum Blue and the Liaison Calprotectin with respect to the Calprest, commonly used assay, and to determine their per...

Descripción completa

Detalles Bibliográficos
Autores principales:	Osredkar, Joško, Kurent, Tina, Fabjan, Teja, Kumer, Kristina, Božnar Alič, Elizabeta, Drobne, David
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Croatian Society of Medical Biochemistry and Laboratory Medicine 2021
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8047788/ https://www.ncbi.nlm.nih.gov/pubmed/33927557 http://dx.doi.org/10.11613/BM.2021.020707

Ejemplares similares

Point-of-care high-sensitivity assay on PATHFAST as the backup in the emergency room
por: Osredkar, Joško, et al.
Publicado: (2021)

Fecal calprotectin in inflammatory bowel disease
por: Walsham, Natalie E, et al.
Publicado: (2016)

Comparison of ADVIA Centaur ultra-sensitive and high-sensitive assays for troponin I in serum
por: Osredkar, Joško, et al.
Publicado: (2022)

Accuracy of three different fecal calprotectin tests in the diagnosis of inflammatory bowel disease
por: Jang, Hui Won, et al.
Publicado: (2016)

The Role of Fecal Calprotectin in Investigating Inflammatory Bowel Diseases
por: Erbayrak, Mustafa, et al.
Publicado: (2009)

Fecal Calprotectin for the Diagnosis and Management of Inflammatory Bowel Diseases
por: Kapel, Nathalie, et al.
Publicado: (2023)

Three Day Environmental Exposure May Trigger Oxidative Stress Development and Provoke Adaptive Response Resulting in Altered Antioxidant Activity
por: ZIMET, Zlatko, et al.
Publicado: (2019)

The usefulness of fecal calprotectin in assessing inflammatory bowel disease activity
por: Lee, Yang Woon, et al.
Publicado: (2019)

Urinary Markers of Oxidative Stress in Children with Autism Spectrum Disorder (ASD)
por: Osredkar, Joško, et al.
Publicado: (2019)

FOCUS: Future of fecal calprotectin utility study in inflammatory bowel disease
por: Rosenfeld, Greg, et al.
Publicado: (2016)

Clinical Performance of a Novel LIAISON Fecal Calprotectin Assay for Differentiation of Inflammatory Bowel Disease From Irritable Bowel Syndrome
por: Campbell, James P., et al.
Publicado: (2021)

Fecal immunochemical test as a biomarker for inflammatory bowel diseases: can it rival fecal calprotectin?
por: Kato, Jun, et al.
Publicado: (2016)

A98 FECAL LEUKOCYTE ESTERASE: AN ALTERNATIVE BIOMARKER TO FECAL CALPROTECTIN IN INFLAMMATORY BOWEL DISEASE
por: Klemm, N K, et al.
Publicado: (2022)

Impact of Fecal Calprotectin Measurement on Decision-making in Children with Inflammatory Bowel Disease
por: El-Matary, Wael, et al.
Publicado: (2017)

From bench to bedside: Fecal calprotectin in inflammatory bowel diseases clinical setting
por: Mumolo, Maria Gloria, et al.
Publicado: (2018)

Detection of calprotectin in inflammatory bowel disease: Fecal and serum levels and immunohistochemical localization
por: Fukunaga, Shuhei, et al.
Publicado: (2018)

Comparison of Fecal Calprotectin Methods for Predicting Relapse of Pediatric Inflammatory Bowel Disease
por: Kittanakom, Saranya, et al.
Publicado: (2017)

Combined Use of Fecal Biomarkers in Inflammatory Bowel Diseases: Oncostatin M and Calprotectin
por: Cao, Ying, et al.
Publicado: (2021)

Association of Fecal Calprotectin With Endoscopic and Histologic Activity in Pediatric Inflammatory Bowel Disease
por: Crawford, Erin, et al.
Publicado: (2021)

A longitudinal study of fecal calprotectin and the development of inflammatory bowel disease in ankylosing spondylitis
por: Klingberg, Eva, et al.
Publicado: (2017)

Could fecal calprotectin enter mainstream use for diagnosing and monitoring inflammatory bowel disease?
por: Wei, Shu Chen
Publicado: (2016)

The Utility of Fecal Calprotectin in the Real-World Clinical Care of Patients with Inflammatory Bowel Disease
por: Abej, Esmail, et al.
Publicado: (2016)

Commentary: Impact of Fecal Calprotectin Measurement on Decision-Making in Children with Inflammatory Bowel Disease
por: Day, Andrew S., et al.
Publicado: (2017)

Fecal Calprotectin in Combination With Standard Blood Tests in the Diagnosis of Inflammatory Bowel Disease in Children
por: Ho, Shaun S. C., et al.
Publicado: (2021)

International consensus on methodological issues in standardization of fecal calprotectin measurement in inflammatory bowel diseases
por: D'Amico, Ferdinando, et al.
Publicado: (2021)

Patient knowledge of fecal calprotectin in inflammatory bowel disease (IBD): An observational study in Mexico
por: Maldonado-Arriaga, Brenda, et al.
Publicado: (2021)

Calprotectin in inflammatory bowel disease
por: Khaki-Khatibi, Fatemeh, et al.
Publicado: (2020)

A comparison of diagnostic performance between two quantitative rapid fecal calprotectin assays in detecting active inflammatory bowel disease
por: Lee, Jong-Mi, et al.
Publicado: (2021)

Is fecal calprotectin always normal in children with irritable bowel syndrome?
por: Choi, You Jin, et al.
Publicado: (2019)

Diagnostic accuracy of fecal calprotectin in assessing the severity of inflammatory bowel disease: From laboratory to clinic
por: Moein, Soheila, et al.
Publicado: (2017)

Diagnostic Accuracy of Fecal Calprotectin for Predicting Relapse in Inflammatory Bowel Disease: A Meta-Analysis
por: Shi, Jin-Tong, et al.
Publicado: (2023)

The Performance of the Xpert Bladder Cancer Monitor Test and Voided Urinary Cytology in the Follow-up of Urinary Bladder Tumors
por: Smrkolj, Tomaz, et al.
Publicado: (2020)

Fecal Calprotectin for Small Bowel Crohn’s Disease: Is It a Cutoff Issue?
por: Romero-Mascarell, Cristina, et al.
Publicado: (2022)

Home-based fecal calprotectin test is expected to play an important role in patients with inflammatory bowel diseases
por: Kim, Young-Ho
Publicado: (2018)

Fecal calprotectin correlates with active colonic inflammatory bowel disease but not with small intestinal Crohn's disease activity
por: Zittan, Eran, et al.
Publicado: (2018)

Fecal calprotectin in daily practice for patients with inflammatory bowel disease: where do we stand in Korea?
por: Cha, Jae Myung
Publicado: (2019)

Clinical utility of fecal calprotectin: potential applications beyond inflammatory bowel disease for the primary care physician
por: Mari, Amir, et al.
Publicado: (2019)

Serum Free Thiols Are Superior to Fecal Calprotectin in Reflecting Endoscopic Disease Activity in Inflammatory Bowel Disease
por: Bourgonje, Arno R., et al.
Publicado: (2019)

Favorable Response to CD34+ Cell Therapy Is Associated with a Decrease of Galectin-3 Levels in Patients with Chronic Heart Failure
por: Poglajen, Gregor, et al.
Publicado: (2019)

Fecal Zonulin as a Noninvasive Biomarker of Intestinal Permeability in Pediatric Patients with Inflammatory Bowel Diseases—Correlation with Disease Activity and Fecal Calprotectin
por: Szymanska, Edyta, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_4ad48j2gbuumfkmlq6jkm97vg2